Accessibility Menu
Vireo Growth logo

Vireo Growth(OTC) VREOF

Market Cap$433.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-93%
5 Year-80%
1 Year-40%
1 Month-7%
$9.37
-0.74%
-0.07Today
Vireo Growth last closing stock price
MetricPriceDate
Last closeUSD 9.372026-07-30
Vireo Growth stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.9%USD 9.752026-07-23
1 month-6.67%USD 10.042026-06-30
3 month-27.36%USD 12.902026-05-01
Year to date-49.04%USD 18.392025-12-31
1 year-39.91%USD 15.592025-07-30
3 year+112.91%USD 4.402023-07-31
5 year-80.48%USD 48.002021-07-30
Since inception-93.16%USD 138.012019-03-25

Vireo Growth Financials at a Glance

Market Cap

$433.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$350.43M

Net Income (TTM)

-$81.91M

EPS (TTM)

-$2.78

P/E Ratio

-3.37

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Price

$9.37

Volume

21,843

Open

$9.44

Previous Close

$9.37

Daily Range

$9.36 - $9.50

52-Week Range

$8.91 - $24.00

Estimated Earnings Date

Aug 12, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vireo Growth

Vireo Growth Inc. is a cannabis company engaged in the cultivation, manufacturing, processing, and distribution of medical and adult-use cannabis products across several states in the U.S. The company operates a network of retail dispensaries and distributors, aiming to provide high-quality cannabis products to its customers.

Products and Services
  • Medical and adult-use cannabis products
  • Retail dispensaries in multiple states
  • Distribution through a network of partners
Growth Outlook
  • Revenue increased to $106.2 million in Q1 2026
  • Gross profit margin improved to 55.8% in Q1 2026
  • Expansion into new markets expected to drive future growth
Financial Highlights
  • Net income of -$20.3 million in Q1 2026
  • Operating income of $9 million in Q1 2026
  • Cash and cash equivalents reached $122.4 million as of March 31, 2026
Vireo Growth Inc. has shown significant revenue growth, with Q1 2026 revenue reaching $106.2 million, reflecting a strong demand for its cannabis products. The gross profit margin has also improved, indicating better cost management and operational efficiency. Despite a net loss of $20.3 million in the same quarter, the company reported an operating income of $9 million, showcasing its ability to generate profits from core operations. The company maintains a robust cash position, with $122.4 million in cash and cash equivalents, providing a solid foundation for future investments and expansion. The strategic focus on entering new markets is expected to further enhance growth prospects, positioning Vireo Growth Inc. as a key player in the evolving cannabis industry.
AI Generated • Jul 29, 2026

Industry

Pharmaceuticals

Employees

612

CEO

John Mazarakis, MBA

Headquarters

Minneapolis, MN 55402, US

VREOF Financials

Key Financial Metrics (TTM)

Gross Margin

49.65%

Operating Margin

3.19%

Net Income Margin

-23.37%

Return on Equity

-29.35%

Return on Capital

1.66%

Return on Assets

-8.82%

Earnings Yield

-29.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$433.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

46.25M

Volume

21.84K

Avg. Volume

13.17K

Financials (TTM)

Gross Profit

$173.98M

Operating Income

$11.19M

EBITDA

$30.96M

Operating Cash Flow

$18.93M

Capital Expenditure

-$39.47M

Free Cash Flow

-$20.54M

Cash & ST Invst.

$123.40M

Total Debt

$405.03M

Vireo Growth Performance Analysis

Vireo Growth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 74,625,86737.1%
20232023-12-31USD 88,133,16318.1%
20242024-12-31USD 99,384,22112.8%
20252025-12-31USD 268,769,268170.4%
Vireo Growth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3095.8%
Q32025-09-3090.7%
Q42025-12-3114.0%
Q12026-03-311.6%
Vireo Growth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -9.9421.8%
20232023-12-31USD -5.67-43.0%
20242024-12-31USD -4.66-17.8%
20252025-12-31USD -2.78-40.3%
Vireo Growth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-50.0%
Q32025-09-308.7%
Q42025-12-3128.1%
Q12026-03-315.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$106.20M

+332.7%

Gross Profit

$59.30M

+377.8%

Gross Margin

55.84%

N/A

Market Cap

$433.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$849.68K

N/A

Employees

510

N/A

Net Income

-$20.30M

-211.9%

EBITDA

$24.06M

+569.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$123.40M

+43.1%

Total Debt

$405.03M

+349.7%

Accounts Receivable

$35.82M

+133.3%

Inventory

$76.10M

+226.0%

Long Term Debt

$381.25M

+328.8%

Short Term Debt

$23.70M

+931.3%

Return on Assets

-8.82%

N/A

Return on Invested Capital

1.57%

N/A

Free Cash Flow

$1.10M

+124.6%

Operating Cash Flow

$11.90M

+458.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INNPFINNOCAN PHARMA Corp
$1.60-8.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$26.97+0.37%
NOKNokia
$9.09+0.08%
SKHYSK Hynix
$149.00+0.18%
TQQQProShares Trust - ProShares UltraPro Qqq
$63.30+0.10%

Questions About VREOF

What is the current price of Vireo Growth?

Vireo Growth is trading at $9.37 per share.

What is the 52-week range for Vireo Growth?

Over the past 52 weeks, Vireo Growth has traded between $8.91 and $24.00.

How much debt does Vireo Growth have?

As of the most recent reporting period, Vireo Growth reported total debt of $403.70M.

How much cash does Vireo Growth have on hand?

Vireo Growth reported $137.80M in cash and cash equivalents in its most recent financial results.

What is Vireo Growth’s dividend yield?

Vireo Growth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.